ABI-H0731: Clinical Trials

6 trials of ABI-H0731, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Terminated 2
Phase 12Completed 2

Follow ABI-H0731: new trials by email Literature Review of ABI-H0731 trials Research Report on ABI-H0731

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection
ABI-H0731, ETV, Peg-IFNα - Chronic Hepatitis B
Phase 2TerminatedAssembly Biosciences542021-02-182023-10-06
A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase Inhibitors
ABI-H0731, Placebo, NrtI - Chronic Hepatitis B
Phase 2TerminatedAssembly Biosciences22020-11-112022-10-20
A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)
ABI-H0731, SOC ETV, Placebo Oral Tablet - Chronic Hepatitis B
Phase 2CompletedAssembly Biosciences252018-06-192021-01-28
A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection
ABI-H0731, SOC NUC, Placebo Oral Tablet - Chronic Hepatitis B
Phase 2CompletedAssembly Biosciences732018-06-112021-02-17
Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B
ABI-H0731, Placebo for ABI-H0731, Entecavir - Chronic Hepatitis B
Phase 1 / Phase 2CompletedAssembly Biosciences382017-06-152018-07-06
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B
ABI-H0731, Placebo for ABI-H0731, Entecavir - Chronic Hepatitis B
Phase 1CompletedAssembly Biosciences862016-11-012019-04-04

Conditions studied

Hepatitis B, Chronic (6)  ·  Hepatitis B (2)

Sponsors

Assembly Biosciences (6)

Countries

New Zealand (4)  ·  Hong Kong (3)  ·  United States (3)  ·  Canada (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  China (1)  ·  South Korea (1)  ·  Taiwan (1)

Top investigators

Grace Wang, MD (1)  ·  Steven Knox (1)

Results publications

PMID 31711752, PMID 35460726, PMID 35697332